Cargando…
MicroRNA-26b suppresses the NF-κB signaling and enhances the chemosensitivity of hepatocellular carcinoma cells by targeting TAK1 and TAB3
BACKGROUND: Abnormal activation of the NF-κB pathway is closely related to tumorigenesis and chemoresistance. Therefore, microRNAs that possess the NF-κB inhibitory activity may provide novel targets for anti-cancer therapy. miR-26 family members have been shown to be frequently downregulated in hep...
Autores principales: | Zhao, Na, Wang, Ruizhi, Zhou, Liangji, Zhu, Ying, Gong, Jiao, Zhuang, Shi-Mei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3938074/ https://www.ncbi.nlm.nih.gov/pubmed/24565101 http://dx.doi.org/10.1186/1476-4598-13-35 |
Ejemplares similares
-
USP18 inhibits NF-κB and NFAT activation during Th17 differentiation by deubiquitinating the TAK1–TAB1 complex
por: Liu, Xikui, et al.
Publicado: (2013) -
Post-Translational Modifications of the TAK1-TAB Complex
por: Hirata, Yusuke, et al.
Publicado: (2017) -
Interleukin-1 and TRAF6-dependent activation of TAK1 in the absence of TAB2 and TAB3
por: Zhang, Jiazhen, et al.
Publicado: (2017) -
A Small Peptide Modeled after the NRAGE Repeat Domain Inhibits XIAP-TAB1-TAK1 Signaling for NF-κB Activation and Apoptosis in P19 Cells
por: Rochira, Jennifer A., et al.
Publicado: (2011) -
TAZ inhibits osteoclastogenesis by attenuating TAK1/NF-κB signaling
por: Yang, Wanlei, et al.
Publicado: (2021)